Laser technologies company Lumibird Medical has launched C.DIAG in Europe, described as a new-generation dry eye diagnostic aid platform incorporating artificial intelligence (AI).
It follows CE marking for the device on 30 April 2024, completing the company’s C.SUITE offering with diagnosis, treatment and education of dry eye patients.
Lumibird Medical said it is now positioned as a unique player in a market estimated to be worth $6.4 billion (AU$9.7 b) in 2024. With dry eye becoming one of the most common reasons for ophthalmological consultations, the company said management of the disease had become a challenge for eyecare professionals, particularly in cases of glaucoma, refractive and cataract surgery, contact lenses, and other specialties such as oncology.
Quantel Medical, a brand of Lumibird Medical and manufacturer of medical devices for 30 years, is bringing C.DIAG to market. It is described as the first automated diagnostic platform for the ocular surface incorporating AI based on algorithms derived from more than one million clinically validated images.
“In the global dry eye market, the share dedicated to medical devices is experiencing the strongest growth, with an estimated increase of more than 20% by 2026,” Lumibird dry eye product manager Ms Delphine Southon said.
“With C.DIAG, we are the only player in this market to offer an automated diagnostic aid platform, the most comprehensive on the market, integrating numerous examinations, with AI and an autofocus HD camera for unrivalled image quality and automatic, accurate and reproducible results.”
Mr Jean-Marc Gendre, CEO of Lumibird Medical, said the company had a goal to become the market leader in medical devices for dry eye with C.SUITE.
“This C.SUITE offer consists of a combination of two top-of-the-range products for diagnostic, C.DIAG, and treatment, C.STIM, complemented by educational communication materials offered to medical centres for patients,” he said.
“The CE mark means we can anticipate sales of several million euros from this range, starting this year.”
More reading
Ellex/Quantel Medical to debut dry eye IPL system at RANZCO virtual
Lumibird Medical-Ellex launches premium YAG/SLT laser Tango Reflex Neo
ACCC concludes investigation, clears Ellex-Lumibird deal
